[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 433
Citations 0
February 20, 2013

Evaluating Other Diseases With Computed Tomographic Screening for Lung Cancer—Reply

Author Affiliations

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

Author Affiliations: Department of Radiology, University Medical Center Utrecht, Utrecht, the Netherlands (Drs Mets and de Jong) (pimdejong@gmail.com); and Department of Radiology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands (Dr Prokop).

JAMA. 2013;309(7):655-656. doi:10.1001/jama.2012.157211

In Reply: The comments by Dr Huesch and colleagues and Dr Wittig address important concerns about screening in smokers and the technical limitations of CT. Screening in current and former smokers is challenging because smoking cessation is the most effective tool for risk reduction, be it cancer risk, cardiovascular risk, or progression of COPD. This potentially makes a negative outcome of screening counterproductive because it might be viewed as an incentive to continue smoking. However, smoking cessation remains difficult in any setting. Adherence is low and the outcome of screening has little long-term influence on smoking behavior.1

First Page Preview View Large
First page PDF preview
First page PDF preview